Lumira Ventures
Toronto, Ontariolumiraventures.com
Overview
Lumira Ventures is Canada's largest and most active healthcare venture capital firm that invests in North American companies developing innovative therapeutics and medical technologies whose products offer transformative improvements to patient health outcomes and meaningful reductions to the overall cost of healthcare delivery . Lumira executes a proven, differentiated investment strategy as a lead investor and active partner to its portfolio companies who are driving forward the next generation of patient care .
Investments
| Company | Date | Stage | Lead |
|---|---|---|---|
| Contraline | Jun 2026 | Series B | Co-investor |
| Nervonik | Apr 2026 | Series B | Co-investor |
| Endogenex | Mar 2026 | Series C Extension | Co-investor |
| Congruence Therapeutics | Mar 2026 | Early Funding | Co-investor |
| Nocion Therapeutics | Jan 2026 | Series B Extension | Co-investor |
Key People
Peter van der Velden
Founder And Managing Partner
Brian Underdown
Venture Partner
Iliana Carroll
Investment Partner
Lu Han 韩路
Partner
Nikhil Thatte
Partner
Suman Rao
Principal
Sector & Stage Mix
Industry, funding stage, and valuation band breakdowns.
